NCT04050098 - Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions

Type2 Diabetes

Interventions

DRUG

gemigliptin 50 mg and metformin hydrochloride 1000 mg prolonged release

"Zemiglo Tablet 50 mg: Each tablet contains gemigliptin tartrate sesquihydrate, equivalent to 50 mg gemigliptin.~Glucophage XR 1000 mg: Each tablet contains metformin hydrochloride 1000 mg (equivalent to 780 mg of metformin base)."

DRUG

Gemigliptin tartrate sesquihydrate and metformin

Each tablet contains gemigliptin tartrate sesquihydrate 68.9 mg (equivalent to gemigliptin pure free base 50 mg) and metformin hydrochloride 1000.0 mg.